Literature DB >> 22836009

SORL1 and SIRT1 mRNA expression and promoter methylation levels in aging and Alzheimer's Disease.

Tatiane Katsue Furuya1, Patrícia Natália Oliveira da Silva, Spencer Luiz Marques Payão, Lucas Trevizani Rasmussen, Roger Willian de Labio, Paulo Henrique Ferreira Bertolucci, Ianna Lacerda Sampaio Braga, Elizabeth Suchi Chen, Gustavo Turecki, Naguib Mechawar, Jonathan Mill, Marília de Arruda Cardoso Smith.   

Abstract

Alzheimer's Disease (AD) is a neurodegenerative disorder and the most common cause of dementia among the elderly. Efforts have been made to understand the genetic and epigenetic mechanisms involved in the development of this disease. As SORL1 (sortilin-related receptor) and SIRT1 (sirtuin 1) genes have been linked to AD pathogenesis, we aimed to investigate their mRNA expression and promoter DNA methylation in post mortem brain tissues (entorhinal and auditory cortices and hippocampus) from healthy elderly subjects and AD patients. We also evaluated these levels in peripheral blood leukocytes from young, healthy elderly and AD patients, investigating whether there was an effect of age on these profiles. The comparative CT method by Real Time PCR and MALDI-TOF mass spectrometry were used to analyze gene expression and DNA methylation, respectively. SORL1 gene was differently expressed in the peripheral blood leukocytes and might act as a marker of aging in this tissue. Furthermore, we found that SORL1 promoter DNA methylation might act as one of the mechanisms responsible for the differences in expression observed between blood and brain for both healthy elderly and AD patients groups. The impact of these studied genes on AD pathogenesis remains to be better clarified.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22836009     DOI: 10.1016/j.neuint.2012.07.014

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  21 in total

1.  Association of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease.

Authors:  Lei Yu; Lori B Chibnik; Gyan P Srivastava; Nathalie Pochet; Jingyun Yang; Jishu Xu; James Kozubek; Nikolaus Obholzer; Sue E Leurgans; Julie A Schneider; Alexander Meissner; Philip L De Jager; David A Bennett
Journal:  JAMA Neurol       Date:  2015-01       Impact factor: 18.302

2.  Exploring the epigenetics of Alzheimer disease.

Authors:  Bryan J Traynor; Alan E Renton
Journal:  JAMA Neurol       Date:  2015-01       Impact factor: 18.302

Review 3.  Epigenomics of Alzheimer's disease.

Authors:  David A Bennett; Lei Yu; Jingyun Yang; Gyan P Srivastava; Cristin Aubin; Philip L De Jager
Journal:  Transl Res       Date:  2014-05-16       Impact factor: 7.012

Review 4.  Epigenetics in Alzheimer's Disease: Perspective of DNA Methylation.

Authors:  Talal Jamil Qazi; Zhenzhen Quan; Asif Mir; Hong Qing
Journal:  Mol Neurobiol       Date:  2017-01-14       Impact factor: 5.590

5.  Blood DNA methylation as a potential biomarker of dementia: A systematic review.

Authors:  Peter D Fransquet; Paul Lacaze; Richard Saffery; John McNeil; Robyn Woods; Joanne Ryan
Journal:  Alzheimers Dement       Date:  2017-11-08       Impact factor: 21.566

6.  Resveratrol Attenuates Aβ25-35 Caused Neurotoxicity by Inducing Autophagy Through the TyrRS-PARP1-SIRT1 Signaling Pathway.

Authors:  Haoyue Deng; Man-Tian Mi
Journal:  Neurochem Res       Date:  2016-05-14       Impact factor: 3.996

Review 7.  The Role of SORL1 in Alzheimer's Disease.

Authors:  Rui-Hua Yin; Jin-Tai Yu; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-05-16       Impact factor: 5.590

8.  Resveratrol inhibits β-amyloid-induced neuronal apoptosis through regulation of SIRT1-ROCK1 signaling pathway.

Authors:  Xiaowen Feng; Nan Liang; Dexiao Zhu; Qing Gao; Lei Peng; Haiman Dong; Qingwei Yue; Haili Liu; Lihua Bao; Jing Zhang; Jing Hao; Yingmao Gao; Xuejie Yu; Jinhao Sun
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

9.  Hunger in the absence of caloric restriction improves cognition and attenuates Alzheimer's disease pathology in a mouse model.

Authors:  Emily J Dhurandhar; David B Allison; Thomas van Groen; Inga Kadish
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

10.  Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype.

Authors:  Giselle Izzo; Orestes V Forlenza; Bernardo dos Santos; Paulo H F Bertolucci; Elida B Ojopi; Wagner F Gattaz; Daniel Shikanai Kerr
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.